INNOSTAR ORD A (SHH) EQSW Exp:
Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is … Read more
INNOSTAR ORD A (SHH) EQSW Exp: (688710) - Total Liabilities
Latest total liabilities as of June 2025: CN¥849.28 Million CNY
Based on the latest financial reports, INNOSTAR ORD A (SHH) EQSW Exp: (688710) has total liabilities worth CN¥849.28 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
INNOSTAR ORD A (SHH) EQSW Exp: - Total Liabilities Trend (2021–2024)
This chart illustrates how INNOSTAR ORD A (SHH) EQSW Exp:'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
INNOSTAR ORD A (SHH) EQSW Exp: Competitors by Total Liabilities
The table below lists competitors of INNOSTAR ORD A (SHH) EQSW Exp: ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Applied Nutrition Plc
LSE:APN
|
UK | GBX20.70 Million |
|
DAIWA SEC GRP - Dusseldorf Stock Exchang
DU:DSE
|
Germany | €30.24 Trillion |
|
PETROBRAS (PJXC.SG)
STU:PJXC
|
Germany | €122.80 Billion |
|
Departure Bay Capital Corp.
V:DBC-P
|
Canada | CA$37.79K |
|
TOKYU CONSTRUCTION
MU:TCW
|
Germany | €171.65 Billion |
|
ArthaLand Corp Preferred Series D
PSE:ALCPD
|
Philippines | ₱23.61 Billion |
|
KwikClick Inc
PINK:KWIK
|
USA | $4.04 Million |
|
Trustpilot Group PLC
LSE:TRST
|
UK | GBX117.35 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down INNOSTAR ORD A (SHH) EQSW Exp:'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INNOSTAR ORD A (SHH) EQSW Exp:'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INNOSTAR ORD A (SHH) EQSW Exp: (2021–2024)
The table below shows the annual total liabilities of INNOSTAR ORD A (SHH) EQSW Exp: from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥817.42 Million | -28.04% |
| 2023-12-31 | CN¥1.14 Billion | -3.46% |
| 2022-12-31 | CN¥1.18 Billion | +12.26% |
| 2021-12-31 | CN¥1.05 Billion | -- |